PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer (2021) Reiß J, Kälble S, Bründl J, Rosenhammer B, Gierth M, Weber F, Eckstein M, et al. Journal article Ist die Expression des GP88-Proteins (Progranulin) ein klinisch relevanter Prognosefaktor für Prostatakarzinompatienten? (2021) Taubert H, Eckstein M Journal article PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives (2021) Gevaert T, Cimadamore A, Montironi R, Eckstein M Journal article Intraoperative free margins assessment of oropharyngeal squamous cell carcinoma with confocal laser endomicroscopy: a pilot study (2021) Sievert M, Stelzle F, Aubreville M, Müller SK, Eckstein M, Oetter N, Maier A, et al. Journal article Feasibility of intraoperative assessment of safe surgical margins during laryngectomy with confocal laser endomicroscopy: A pilot study (2021) Sievert M, Oetter N, Aubreville M, Stelzle F, Maier A, Eckstein M, Mantsopoulos K, et al. Journal article POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer (2021) Wahby S, Jarczyk J, Fierek A, Heinkele J, Weis CA, Eckstein M, Martini T, et al. Journal article Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders (2020) Weyerer V, Lange F, Wullweber A, Stöhr R, Bertz S, Wach S, Taubert H, et al. Conference contribution Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer (2020) Wu S, Nitschke K, Worst TS, Fierek A, Weis CA, Eckstein M, Porubsky S, et al. Journal article Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer (2020) Devlies W, Eckstein M, Cimadamore A, Devos G, Moris L, Van Den Broeck T, Montironi R, et al. Journal article, Review article Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution